Adam Durbin

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Adam Durbin

Aug 20, 2024, 15:58 | Blog

Adam Durbin: Our recent review of cell state in neuroblastoma

Adam Durbin, Assistant Member in the Division of Molecular Oncology at St. Jude Children’s Research Hospital, posted on X about recent…

Aug 8, 2024, 09:45 | Blog

Jun Qi: So excited to get support at St. Baldrick's Foundation

Jun Qi, Assistant Professor of Medicine at Dana-Farber Cancer Institute, shared a post on X…

Aug 3, 2024, 10:08 | Insight

Dean Crowe: $500,000 of congrats to the new Rally-Funded Outside the Box Researchers

Dean Crowe, Founder and CEO at the Rally Foundation for Childhood Cancer Research, shared on LinkedIn:…

May 1, 2024, 01:17 | Blog

Jun Qi: Our article on EP300/CBP bromodomain inhibition in Group 3 medulloblastoma is now published

Jun Qi, Assistant Professor of Medicine at Dana-Farber Cancer Institute, shared a post on LinkedIn:…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023